nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00647	0.00647	CbGpPWpGaD
Solifenacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00637	0.00637	CbGpPWpGaD
Solifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00607	0.00607	CbGpPWpGaD
Solifenacin—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00601	0.00601	CbGpPWpGaD
Solifenacin—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00599	0.00599	CbGpPWpGaD
Solifenacin—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00593	0.00593	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00586	0.00586	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00572	0.00572	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00561	0.00561	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00553	0.00553	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00537	0.00537	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00529	0.00529	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00522	0.00522	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00519	0.00519	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00517	0.00517	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00512	0.00512	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00508	0.00508	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00503	0.00503	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00502	0.00502	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00502	0.00502	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.005	0.005	CbGpPWpGaD
Solifenacin—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00487	0.00487	CbGpPWpGaD
Solifenacin—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00485	0.00485	CbGpPWpGaD
Solifenacin—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00481	0.00481	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0048	0.0048	CbGpPWpGaD
Solifenacin—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0048	0.0048	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00461	0.00461	CbGpPWpGaD
Solifenacin—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0046	0.0046	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00456	0.00456	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00395	0.00395	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00394	0.00394	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0039	0.0039	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00373	0.00373	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00371	0.00371	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00368	0.00368	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00352	0.00352	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00351	0.00351	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00347	0.00347	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00331	0.00331	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00324	0.00324	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00323	0.00323	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00304	0.00304	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00301	0.00301	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00296	0.00296	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00295	0.00295	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00291	0.00291	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00284	0.00284	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00276	0.00276	CbGpPWpGaD
Solifenacin—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00275	0.00275	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Solifenacin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Solifenacin—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00263	0.00263	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.0026	0.0026	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00259	0.00259	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00248	0.00248	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Solifenacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00205	0.00205	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00198	0.00198	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00183	0.00183	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00183	0.00183	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00174	0.00174	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00164	0.00164	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00162	0.00162	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00099	0.00099	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.000963	0.000963	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000929	0.000929	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.000923	0.000923	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000921	0.000921	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000913	0.000913	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000898	0.000898	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000889	0.000889	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.000882	0.000882	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00086	0.00086	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000779	0.000779	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000777	0.000777	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000773	0.000773	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000769	0.000769	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000763	0.000763	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000756	0.000756	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.00074	0.00074	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.00074	0.00074	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000726	0.000726	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000707	0.000707	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000705	0.000705	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000698	0.000698	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000672	0.000672	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000656	0.000656	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000656	0.000656	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.00065	0.00065	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000648	0.000648	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000644	0.000644	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000641	0.000641	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000626	0.000626	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000624	0.000624	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000621	0.000621	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.00062	0.00062	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000619	0.000619	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000613	0.000613	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000612	0.000612	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000605	0.000605	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000603	0.000603	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000598	0.000598	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000594	0.000594	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000593	0.000593	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000586	0.000586	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000568	0.000568	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000521	0.000521	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000514	0.000514	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000498	0.000498	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000489	0.000489	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000453	0.000453	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000452	0.000452	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000448	0.000448	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000442	0.000442	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000424	0.000424	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000418	0.000418	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000417	0.000417	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000413	0.000413	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000413	0.000413	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000411	0.000411	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000407	0.000407	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.0004	0.0004	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000399	0.000399	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000397	0.000397	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000395	0.000395	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000357	0.000357	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.00035	0.00035	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000336	0.000336	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000298	0.000298	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000297	0.000297	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000294	0.000294	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000294	0.000294	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000289	0.000289	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000284	0.000284	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000282	0.000282	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000236	0.000236	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000236	0.000236	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000233	0.000233	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000198	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000198	0.000198	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000196	0.000196	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000195	0.000195	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000155	0.000155	CbGpPWpGaD
